In recent years, biotechnologically derived peptide and protein-based drugs have developed into mainstream therapeutic agents. Peptide and protein drugs now constitute a substantial portion of the compounds under preclinical and clinical development in the global pharmaceutical industry. Pharmacokin
β¦ LIBER β¦
Aspects of biotechnology in steriod biotransformation
β Scribed by Prof. Dr. V. S. Malik
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 402 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0233-111X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Due to the increasing world population, supply of steroids is dwindling. New sources of steroids is dwindling. New Sources of steroids may be found and the existing steroids and sterols may be better utilized. The role of biotechnology in the production and efficient utilization of steroids and sterols is discussed.
π SIMILAR VOLUMES
Pharmacokinetic aspects of biotechnology
β
Lisa Tang; Adam M. Persky; GΓΌnther Hochhaus; Bernd Meibohm
π
Article
π
2004
π
John Wiley and Sons
π
English
β 205 KB
Biotechnological aspects of antibody pro
β
A. PlΓΌckthun
π
Article
π
1991
π
John Wiley and Sons
π
English
β 652 KB
Industrial Biotechnology (Sustainable Gr
β
Soetaert, Wim; Vandamme, Erick J.
π
Article
π
2010
π
Wiley-VCH Verlag GmbH & Co. KGaA
β 201 KB
π 2 views
Terpenoid biotransformation in mammals I
β
T. Ishida; Y. Asakawa; T. Takemoto; T. Aratani
π
Article
π
1979
π
John Wiley and Sons
π
English
β 362 KB
Biotransformation of isosorbide dinitrat
β
W. H. Down; L. F. Chasseaud; R. K. Grundy
π
Article
π
1974
π
John Wiley and Sons
π
English
β 274 KB
ChemInform Abstract: Rhodiola rosea L.:
β
V. A. Bykov; G. G. Zapesochnaya; V. A. Kurkin
π
Article
π
2010
π
John Wiley and Sons
β 25 KB